- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06932263
Dosisområde Finding af undersøgelse for at vurdere effektivitet og sikkerhed af Tozorakimab hos voksne med ukontrolleret astma på mellemstor-til-høj dosis inhalerede kortikosteroider (Umbriel)
En fase IIB, multicentre, dobbeltblind, placebokontrolleret dosisområde Finding af undersøgelse for at vurdere effektivitet og sikkerhed af Tozorakimab hos voksne deltagere med ukontrolleret astma på mellemstor til høj dosis inhalerede kortikosteroider
This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Fase 2
Kontakter og lokationer
Studiekontakt
- Navn: AstraZeneca Clinical Study Information Center
- Telefonnummer: 1-877-240-9479
- E-mail: information.center@astrazeneca.com
Studiesteder
-
-
-
CABA, Argentina, C1425BEN
- Rekruttering
- Research Site
-
Ciudad de Buenos Aires, Argentina, 1128
- Trukket tilbage
- Research Site
-
Ciudad de Buenos Aires, Argentina, 1425
- Rekruttering
- Research Site
-
La Plata, Argentina, B1900
- Rekruttering
- Research Site
-
Mendoza, Argentina, 5500
- Rekruttering
- Research Site
-
Rosario, Argentina, 2000
- Rekruttering
- Research Site
-
San Miguel de Tucumán, Argentina, 4000
- Rekruttering
- Research Site
-
-
-
-
-
Caxias do Sul, Brasilien, 95070-560
- Trukket tilbage
- Research Site
-
Criciúma, Brasilien, 88811-000
- Rekruttering
- Research Site
-
Porto Alegre, Brasilien, 91350-200
- Rekruttering
- Research Site
-
Porto Alegre, Brasilien, 90610-001
- Rekruttering
- Research Site
-
Salvador, Brasilien, 40050 410
- Trukket tilbage
- Research Site
-
Santo André, Brasilien, 09080-110
- Trukket tilbage
- Research Site
-
Sorocaba, Brasilien, 18040-425
- Rekruttering
- Research Site
-
São José do Rio Preto, Brasilien, 15090-000
- Rekruttering
- Research Site
-
São Paulo, Brasilien, 05403-000
- Rekruttering
- Research Site
-
São Paulo, Brasilien, 04014-002
- Rekruttering
- Research Site
-
-
-
-
-
Curicó, Chile, 3341643
- Aktiv, ikke rekrutterende
- Research Site
-
Quillota, Chile, 2260000
- Aktiv, ikke rekrutterende
- Research Site
-
Santiago, Chile, 7500657
- Aktiv, ikke rekrutterende
- Research Site
-
Santiago, Chile, 7501126
- Aktiv, ikke rekrutterende
- Research Site
-
Santiago, Chile, 7750495
- Aktiv, ikke rekrutterende
- Research Site
-
Temuco, Chile, 4810345
- Aktiv, ikke rekrutterende
- Research Site
-
Viña del Mar, Chile, 2540488
- Aktiv, ikke rekrutterende
- Research Site
-
-
-
-
-
Iloilo City, Filippinerne, 5000
- Rekruttering
- Research Site
-
Las Piñas, Filippinerne, 1742
- Trukket tilbage
- Research Site
-
Lipa, Filippinerne, 4217
- Rekruttering
- Research Site
-
Manadaluyong City, Filippinerne, 1552
- Rekruttering
- Research Site
-
Quezon City, Filippinerne, 1100
- Rekruttering
- Research Site
-
Roxas City, Filippinerne, 5800
- Trukket tilbage
- Research Site
-
-
-
-
California
-
Bakersfield, California, Forenede Stater, 93301
- Rekruttering
- Research Site
-
Huntington Beach, California, Forenede Stater, 92647
- Trukket tilbage
- Research Site
-
La Mesa, California, Forenede Stater, 91942
- Afsluttet
- Research Site
-
Loma Linda, California, Forenede Stater, 92354
- Trukket tilbage
- Research Site
-
Long Beach, California, Forenede Stater, 90815
- Rekruttering
- Research Site
-
Newport Beach, California, Forenede Stater, 92663
- Rekruttering
- Research Site
-
San Jose, California, Forenede Stater, 95117
- Rekruttering
- Research Site
-
-
Delaware
-
Wilmington, Delaware, Forenede Stater, 19805
- Afsluttet
- Research Site
-
-
Florida
-
Cutler Bay, Florida, Forenede Stater, 33189
- Suspenderet
- Research Site
-
Hialeah, Florida, Forenede Stater, 33015
- Suspenderet
- Research Site
-
Leesburg, Florida, Forenede Stater, 34748
- Trukket tilbage
- Research Site
-
Miami, Florida, Forenede Stater, 33175
- Suspenderet
- Research Site
-
Miami, Florida, Forenede Stater, 33155
- Suspenderet
- Research Site
-
Miami Lakes, Florida, Forenede Stater, 33016
- Suspenderet
- Research Site
-
Orlando, Florida, Forenede Stater, 32819
- Suspenderet
- Research Site
-
Palmetto Bay, Florida, Forenede Stater, 33157
- Suspenderet
- Research Site
-
Tampa, Florida, Forenede Stater, 33607
- Suspenderet
- Research Site
-
Winter Park, Florida, Forenede Stater, 32789
- Suspenderet
- Research Site
-
-
Idaho
-
Boise, Idaho, Forenede Stater, 83706
- Trukket tilbage
- Research Site
-
-
Indiana
-
Noblesville, Indiana, Forenede Stater, 46060
- Rekruttering
- Research Site
-
-
Iowa
-
West Des Moines, Iowa, Forenede Stater, 50266
- Afsluttet
- Research Site
-
-
Kansas
-
Hutchinson, Kansas, Forenede Stater, 67502
- Rekruttering
- Research Site
-
Kansas City, Kansas, Forenede Stater, 66160
- Trukket tilbage
- Research Site
-
-
Kentucky
-
Louisville, Kentucky, Forenede Stater, 40218
- Rekruttering
- Research Site
-
-
Maryland
-
White Marsh, Maryland, Forenede Stater, 21162
- Trukket tilbage
- Research Site
-
-
Massachusetts
-
Worcester, Massachusetts, Forenede Stater, 01605
- Rekruttering
- Research Site
-
-
Michigan
-
Farmington Hills, Michigan, Forenede Stater, 48336
- Rekruttering
- Research Site
-
Warren, Michigan, Forenede Stater, 48088
- Trukket tilbage
- Research Site
-
-
Missouri
-
St Louis, Missouri, Forenede Stater, 63141
- Trukket tilbage
- Research Site
-
-
Nebraska
-
Bellevue, Nebraska, Forenede Stater, 68123
- Trukket tilbage
- Research Site
-
Grand Island, Nebraska, Forenede Stater, 68803
- Rekruttering
- Research Site
-
Omaha, Nebraska, Forenede Stater, 68134
- Rekruttering
- Research Site
-
-
New Jersey
-
Millville, New Jersey, Forenede Stater, 08332
- Ikke rekrutterer endnu
- Research Site
-
Mullica Hill, New Jersey, Forenede Stater, 08062
- Rekruttering
- Research Site
-
Toms River, New Jersey, Forenede Stater, 08755
- Rekruttering
- Research Site
-
-
New York
-
Horseheads, New York, Forenede Stater, 14845
- Rekruttering
- Research Site
-
Maspeth, New York, Forenede Stater, 11378
- Rekruttering
- Research Site
-
-
North Carolina
-
Asheville, North Carolina, Forenede Stater, 28803
- Trukket tilbage
- Research Site
-
Huntersville, North Carolina, Forenede Stater, 28078
- Trukket tilbage
- Research Site
-
Kings Mountain, North Carolina, Forenede Stater, 28086
- Rekruttering
- Research Site
-
Pinehurst, North Carolina, Forenede Stater, 28374
- Trukket tilbage
- Research Site
-
-
Ohio
-
Toledo, Ohio, Forenede Stater, 43617
- Rekruttering
- Research Site
-
-
Oklahoma
-
Edmond, Oklahoma, Forenede Stater, 73034
- Trukket tilbage
- Research Site
-
-
Oregon
-
Grants Pass, Oregon, Forenede Stater, 97527
- Trukket tilbage
- Research Site
-
Medford, Oregon, Forenede Stater, 97504
- Rekruttering
- Research Site
-
Portland, Oregon, Forenede Stater, 97202
- Rekruttering
- Research Site
-
-
Pennsylvania
-
DuBois, Pennsylvania, Forenede Stater, 15801
- Afsluttet
- Research Site
-
Philadelphia, Pennsylvania, Forenede Stater, 19140
- Rekruttering
- Research Site
-
Smithfield, Pennsylvania, Forenede Stater, 15478
- Rekruttering
- Research Site
-
-
South Carolina
-
Rock Hill, South Carolina, Forenede Stater, 29732
- Rekruttering
- Research Site
-
-
Tennessee
-
Knoxville, Tennessee, Forenede Stater, 37919
- Afsluttet
- Research Site
-
-
Texas
-
Austin, Texas, Forenede Stater, 78759
- Rekruttering
- Research Site
-
Boerne, Texas, Forenede Stater, 78006
- Rekruttering
- Research Site
-
Dallas, Texas, Forenede Stater, 75254
- Rekruttering
- Research Site
-
El Paso, Texas, Forenede Stater, 79912
- Rekruttering
- Research Site
-
Forney, Texas, Forenede Stater, 75126
- Afsluttet
- Research Site
-
Greenville, Texas, Forenede Stater, 75401
- Rekruttering
- Research Site
-
Kingwood, Texas, Forenede Stater, 77339
- Rekruttering
- Research Site
-
McKinney, Texas, Forenede Stater, 75069
- Trukket tilbage
- Research Site
-
Sugar Land, Texas, Forenede Stater, 77478
- Rekruttering
- Research Site
-
Victoria, Texas, Forenede Stater, 77901
- Rekruttering
- Research Site
-
-
Utah
-
Roy, Utah, Forenede Stater, 84067
- Afsluttet
- Research Site
-
-
Washington
-
Bellingham, Washington, Forenede Stater, 98225
- Afsluttet
- Research Site
-
-
West Virginia
-
Kingwood, West Virginia, Forenede Stater, 26537
- Rekruttering
- Research Site
-
-
Wisconsin
-
Milwaukee, Wisconsin, Forenede Stater, 53228
- Rekruttering
- Research Site
-
-
-
-
-
Brest, Frankrig, 29200
- Rekruttering
- Research Site
-
Créteil, Frankrig, 94010
- Rekruttering
- Research Site
-
Lyon, Frankrig, 69317
- Rekruttering
- Research Site
-
Marseille, Frankrig, 13015
- Rekruttering
- Research Site
-
Pessac, Frankrig, 33604
- Rekruttering
- Research Site
-
Strasbourg, Frankrig, 67091
- Rekruttering
- Research Site
-
Suresnes, Frankrig, 92150
- Rekruttering
- Research Site
-
-
-
-
-
Athens, Grækenland, 11521
- Aktiv, ikke rekrutterende
- Research Site
-
Athens, Grækenland, 17562
- Aktiv, ikke rekrutterende
- Research Site
-
Ioannina, Grækenland, 45500
- Trukket tilbage
- Research Site
-
Pátrai, Grækenland, 26504
- Aktiv, ikke rekrutterende
- Research Site
-
Thessaloniki, Grækenland, 57010
- Aktiv, ikke rekrutterende
- Research Site
-
Thessaloniki, Grækenland, 57001
- Suspenderet
- Research Site
-
-
-
-
-
Belagavi, Indien, 590010
- Rekruttering
- Research Site
-
Coimbatore, Indien, 641028
- Rekruttering
- Research Site
-
Dehradun, Indien, 248001
- Rekruttering
- Research Site
-
Delhi, Indien, 110029
- Rekruttering
- Research Site
-
Faridabad, Indien, 121012
- Trukket tilbage
- Research Site
-
Gūrgaon, Indien, 122001
- Trukket tilbage
- Research Site
-
Kochi, Indien, 682027
- Afsluttet
- Research Site
-
Lucknow, Indien, 226003
- Suspenderet
- Research Site
-
New Delhi, Indien, 110005
- Rekruttering
- Research Site
-
Vadodara, Indien, 391760
- Rekruttering
- Research Site
-
-
-
-
-
Haifa, Israel, 3109601
- Rekruttering
- Research Site
-
Jerusalem, Israel, 91120
- Rekruttering
- Research Site
-
Kfar Saba, Israel, 44281
- Rekruttering
- Research Site
-
Ramat Gan, Israel, 52621
- Rekruttering
- Research Site
-
Rehovot, Israel, 76100
- Rekruttering
- Research Site
-
-
-
-
-
Catania, Italien, 95123
- Rekruttering
- Research Site
-
Foggia, Italien, 71100
- Rekruttering
- Research Site
-
Genoa, Italien, 16132
- Rekruttering
- Research Site
-
Roma, Italien, 00168
- Rekruttering
- Research Site
-
-
-
-
-
Fukuoka, Japan, 811-1394
- Rekruttering
- Research Site
-
Ginowan-shi, Japan, 901-2214
- Rekruttering
- Research Site
-
Hiroshima, Japan, 730-0013
- Rekruttering
- Research Site
-
Ishinomaki, Japan, 986-8522
- Rekruttering
- Research Site
-
Kawaguchi-shi, Japan, 332-8558
- Rekruttering
- Research Site
-
Kiyose-shi, Japan, 204-8585
- Rekruttering
- Research Site
-
Kobe, Japan, 650-0017
- Rekruttering
- Research Site
-
Meguro-ku, Japan, 152-8902
- Rekruttering
- Research Site
-
Miura, Japan, 238-0111
- Rekruttering
- Research Site
-
Neyagawa, Japan, 572-8551
- Rekruttering
- Research Site
-
Sapporo, Japan, 064-0804
- Rekruttering
- Research Site
-
Sapporo, Japan, 060-0033
- Rekruttering
- Research Site
-
Takamatsu, Japan, 761-8073
- Rekruttering
- Research Site
-
Ube, Japan, 755-8505
- Rekruttering
- Research Site
-
Yokohama, Japan, 232-0066
- Rekruttering
- Research Site
-
Yokohama, Japan, 245-8575
- Rekruttering
- Research Site
-
Yokohama, Japan, 232-0024
- Rekruttering
- Research Site
-
-
-
-
-
Baotou, Kina, 014010
- Rekruttering
- Research Site
-
Changchun, Kina, 130021
- Rekruttering
- Research Site
-
Chengdu, Kina, 610000
- Rekruttering
- Research Site
-
Chongqing, Kina, 400010
- Rekruttering
- Research Site
-
Guangzhou, Kina, 510163
- Rekruttering
- Research Site
-
Haikou, Kina, 570311
- Rekruttering
- Research Site
-
Hefei, Kina, 230061
- Rekruttering
- Research Site
-
Hohhot, Kina, 10050
- Rekruttering
- Research Site
-
Huizhou, Kina, 516001
- Rekruttering
- Research Site
-
Qingdao, Kina, 266011
- Rekruttering
- Research Site
-
Shanghai, Kina, 200025
- Rekruttering
- Research Site
-
Shanghai, Kina, 200065
- Rekruttering
- Research Site
-
Shanghai, Kina, 201114
- Rekruttering
- Research Site
-
Shenzhen, Kina, 518020
- Rekruttering
- Research Site
-
Wenzhou, Kina, 325027
- Rekruttering
- Research Site
-
Xuzhou, Kina, 221000
- Rekruttering
- Research Site
-
-
-
-
-
Lima, Peru, 15046
- Aktiv, ikke rekrutterende
- Research Site
-
Lima, Peru, LIMA 21
- Trukket tilbage
- Research Site
-
Lima, Peru, 15088
- Aktiv, ikke rekrutterende
- Research Site
-
Lima, Peru, LIMA 33
- Trukket tilbage
- Research Site
-
Lima, Peru, 15082
- Aktiv, ikke rekrutterende
- Research Site
-
Lima, Peru, LIMA 1
- Aktiv, ikke rekrutterende
- Research Site
-
-
-
-
-
Barcelona, Spanien, 08003
- Rekruttering
- Research Site
-
Barcelona, Spanien, 8025
- Rekruttering
- Research Site
-
Madrid, Spanien, 28041
- Rekruttering
- Research Site
-
Málaga, Spanien, 29010
- Rekruttering
- Research Site
-
Mérida, Spanien, 06800
- Trukket tilbage
- Research Site
-
Patraix, Spanien, 46017
- Rekruttering
- Research Site
-
Santander, Spanien, 39008
- Rekruttering
- Research Site
-
-
-
-
-
Bellville, Sydafrika, 7530
- Rekruttering
- Research Site
-
Benoni, Sydafrika, 1501
- Rekruttering
- Research Site
-
Brackenfell, Sydafrika, 7560
- Rekruttering
- Research Site
-
Cape Town, Sydafrika, 7700
- Rekruttering
- Research Site
-
Durban, Sydafrika, 4093
- Rekruttering
- Research Site
-
Somerset West, Sydafrika, 7130
- Rekruttering
- Research Site
-
eMkhomazi, Sydafrika, 4170
- Rekruttering
- Research Site
-
-
-
-
-
Cheongju-si, Sydkorea, 28644
- Aktiv, ikke rekrutterende
- Research Site
-
Daegu, Sydkorea, 42415
- Aktiv, ikke rekrutterende
- Research Site
-
Seoul, Sydkorea, 03080
- Rekruttering
- Research Site
-
Seoul, Sydkorea, 03722
- Aktiv, ikke rekrutterende
- Research Site
-
Seoul, Sydkorea, 08308
- Aktiv, ikke rekrutterende
- Research Site
-
Seoul, Sydkorea, 05505
- Aktiv, ikke rekrutterende
- Research Site
-
Seoul, Sydkorea, 03312
- Aktiv, ikke rekrutterende
- Research Site
-
Seoul, Sydkorea, 06591
- Afsluttet
- Research Site
-
-
-
-
-
Kaohsiung City, Taiwan, 80756
- Rekruttering
- Research Site
-
New Taipei City, Taiwan, 231
- Trukket tilbage
- Research Site
-
Taichung, Taiwan, 40705
- Rekruttering
- Research Site
-
Taichung, Taiwan, 433004
- Rekruttering
- Research Site
-
Taipei, Taiwan, 10002
- Rekruttering
- Research Site
-
Taipei, Taiwan, 11220
- Rekruttering
- Research Site
-
Taipei, Taiwan, 110
- Rekruttering
- Research Site
-
Taipei, Taiwan, 11696
- Rekruttering
- Research Site
-
-
-
-
-
Bangkok, Thailand, 10700
- Rekruttering
- Research Site
-
Chanthaburi, Thailand, 22000
- Rekruttering
- Research Site
-
Chiang Rai, Thailand, 57000
- Rekruttering
- Research Site
-
Chon Buri, Thailand, 20000
- Rekruttering
- Research Site
-
Khon Kaen, Thailand, 40002
- Rekruttering
- Research Site
-
Nakhon Sri Thammarat, Thailand, 80000
- Rekruttering
- Research Site
-
-
-
-
-
Adana, Tyrkiet (Türkiye), 01330
- Rekruttering
- Research Site
-
Ankara, Tyrkiet (Türkiye), 06280
- Rekruttering
- Research Site
-
Bursa, Tyrkiet (Türkiye), 16059
- Rekruttering
- Research Site
-
Gaziantep, Tyrkiet (Türkiye), 27470
- Rekruttering
- Research Site
-
Istanbul, Tyrkiet (Türkiye), 34890
- Rekruttering
- Research Site
-
Kayseri, Tyrkiet (Türkiye), 38039
- Rekruttering
- Research Site
-
Mersin, Tyrkiet (Türkiye), 33079
- Rekruttering
- Research Site
-
-
-
-
-
Balassagyarmat, Ungarn, 2660
- Aktiv, ikke rekrutterende
- Research Site
-
Budapest, Ungarn, 1121
- Trukket tilbage
- Research Site
-
Budapest, Ungarn, 1036
- Trukket tilbage
- Research Site
-
Debrecen, Ungarn, 4032
- Aktiv, ikke rekrutterende
- Research Site
-
Gödöllő, Ungarn, 2100
- Aktiv, ikke rekrutterende
- Research Site
-
Pécs, Ungarn, 7635
- Aktiv, ikke rekrutterende
- Research Site
-
Törökbálint, Ungarn, 2045
- Aktiv, ikke rekrutterende
- Research Site
-
-
-
-
-
Da Nang, Vietnam, 550000
- Rekruttering
- Research Site
-
Haiphong, Vietnam, 180000
- Rekruttering
- Research Site
-
Hanoi, Vietnam, 100000
- Rekruttering
- Research Site
-
Ho Chi Minh City, Vietnam, 700000
- Rekruttering
- Research Site
-
Ho Chi Minh City, Vietnam, 700000
- Trukket tilbage
- Research Site
-
Ho Chi Minh City, Vietnam, 10000
- Rekruttering
- Research Site
-
Huế, Vietnam, 530000
- Rekruttering
- Research Site
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
-
Provision of signed and dated written informed consent prior to any study-specific procedures.
-
Adults aged 18-75, inclusive when signing the informed consent.
-
Documented physician-diagnosis of asthma for at least 12 months.
-
Treated with medium or high dose ICS in combination with LABA.
-
Demonstration of uncontrolled asthma through ACQ-6 score ≥ 1.5 .
-
Pre-bronchodilator FEV1 ≥ 40% to ≤ 90% of predicted normal.
-
Documented exacerbation history in the last 12 months and biomarker requirements of:
- ≥ 2 severe exacerbations OR
- 1 severe exacerbation and:
(i) Eosinophils ≥ 150 cells/µl or (ii) FeNo ≥ 25 ppb
-
Participants need to demonstrate a ≥70% compliance for Asthma Daily Diary.
-
Women of Child Bearing Potential (WOCBP) must have a negative pregnancy test.
-
Contraceptive use by males and females should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.
Exclusion Criteria:
- Completed treatment for respiratory infection with antibiotics in the 4 weeks prior to Visit 1.
- Clinically significant pulmonary disease other than asthma .
- Current smokers, former smokers with >10 pack-years history.
- Clinically significant aortic stenosis or pulmonary arterial hypertension.
- Active tuberculosis, hepatitis, HIV, or current diagnosis of cancer or immune complex disease.
- Unstable cardiovascular disorders.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Tozorakimab Dose 1
Dosing subcutaneously tozorakimab Dose 1 |
The drug will be administered subcutaneously. |
|
Eksperimentel: Tozorakimab Dose 2
Dosing subcutaneously tozorakimab Dose 2 and placebo |
The drug will be administered subcutaneously. |
|
Placebo komparator: Placebo
Dosing subcutaneously with equivalent volume to tozorakimab |
Placebo will be administered subcutaneously. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Annualised rate of severe asthma exacerbations
Tidsramme: Over 26 to 52 weeks
|
The rate ratio of severe asthma exacerbations will be assessed in the participants with uncontrolled moderate-to-severe asthma and ≥ 1 severe exacerbation within 12 months prior to screening. |
Over 26 to 52 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Annualised rate of severe asthma exacerbations
Tidsramme: Over 26 to 52 weeks
|
The rate ratio of severe asthma exacerbations will be assessed in the participants with uncontrolled moderate-to-severe asthma and baseline eosinophils < 300 cells/µL and history of ≥2 severe exacerbations within 12 months prior to screening. |
Over 26 to 52 weeks
|
|
Time to first severe asthma exacerbation
Tidsramme: Over 26 to 52 weeks
|
To evaluate the effect of two dose levels of tozorakimab compared to placebo on time to first severe asthma exacerbations. |
Over 26 to 52 weeks
|
|
Change from baseline in pre-bronchodilator forced expiratory volume in 1 second (FEV1)
Tidsramme: Over weeks 20 to 26
|
Difference in mean change from baseline between tozorakimab and placebo. |
Over weeks 20 to 26
|
|
Change from baseline in post-bronchodilator FEV1
Tidsramme: At week 26
|
Difference in mean change from baseline between tozorakimab and placebo. |
At week 26
|
|
Change from baseline in the Asthma Control Questionnaire 6 (ACQ-6)
Tidsramme: At week 26
|
Difference in mean change from baseline between tozorakimab and placebo. The ACQ-6 has 6 questions (regarding asthma symptoms and rescue bronchodilator use). Answering the questions results in a score out of 6. A Score of 0 indicates complete control and 6 reflects severely uncontrolled disease. |
At week 26
|
|
Change from baseline in the Asthma Quality of Life Questionnaire for 12 Years and Older (AQLQ12+)
Tidsramme: At week 26
|
Difference in mean change from baseline between tozorakimab and placebo. The AQLQ12+ includes 32 questions grouped into four domains: symptoms; activity limitations; emotional function; and, environmental stimuli. Each question is scored on a seven-point Likert scale, which ranges from 7 (no impairment) to 1 (severe impairment). The overall score is calculated as the mean of all questions, and the four domain scores are the means of the scores for the questions in the respective domains. |
At week 26
|
|
Trough serum concentrations of tozorakimab
Tidsramme: Over 52 weeks
|
Pharmacokinetics: concentrations of tozorakimab in trough serum. |
Over 52 weeks
|
|
Anti-drug antibody incidence
Tidsramme: Over 52 weeks
|
Immunogenicity: Number of Participants With Positive Antibodies to tozorakimab |
Over 52 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- D9181C00002
- 2024-519116-14-00 (Registry Identifier: CTIS)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal Vivli.org. All requests will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure. Yes, indicates that AZ are accepting requests for IPD, but this does not mean all requests will be shared.
IPD-delingstidsramme
AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA PhRMA Data Sharing Principles. For details of our timelines, please rerefer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.
IPD-delingsadgangskriterier
When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org.
Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information.
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .